{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:31:06Z","timestamp":1784248266339,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.yrtph.2020.104781","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T09:20:53Z","timestamp":1599211253000},"page":"104781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A 26-week toxicological study of Xuezhikang (XZK), red yeast rice extract, in Beagle dogs with a 4-week recovery period"],"prefix":"10.1016","volume":"117","author":[{"given":"Chunmei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2020.104781_bib1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/0886022X.2016.1207052","article-title":"Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis","volume":"38","author":"Chu","year":"2016","journal-title":"Ren. Fail."},{"key":"10.1016\/j.yrtph.2020.104781_bib2","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41401-018-0039-1","article-title":"Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules","volume":"39","author":"Feng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yrtph.2020.104781_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104654","article-title":"Toxicological evaluation of, red rice yeast extract, Xuezhikang: acute, 26-week chronic and genotoxicity studies","author":"Gao","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2017.06.024","article-title":"Nonclinical safety of Astilbin: a 4-week oral toxicity study in rats with genotoxicity, chromosomal aberration, and mammalian micronucleus tests","author":"Gao","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2020.104781_bib5","article-title":"A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs","volume":"110","author":"Gao","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110578","article-title":"Preclinical safety of ginsenoside compound K: acute, and 26-week oral toxicity studies in mice and rats","volume":"131","author":"Gao","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2020.104781_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yrtph.2017.04.009","article-title":"Repeated sub-chronic oral toxicity study of xylooligosaccharides (XOS) in dogs","volume":"86","author":"Gao","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yrtph.2018.10.008","article-title":"Toxicity effects of a novel potent triple reuptake inhibitor, LPM570065, on the fertility and early embryonic development in Sprague-Dawley rats","volume":"100","author":"Guo","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib9","first-page":"390","article-title":"Chinese guidelines on prevention and treatment of dyslipidemia in adults","volume":"35","author":"Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults","year":"2007","journal-title":"Chin. J. Cardiol."},{"key":"10.1016\/j.yrtph.2020.104781_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yrtph.2018.07.011","article-title":"Acute, subchronic oral toxicity, and genotoxicity evaluations of LPM570065, a new potent triple reuptake inhibitor","volume":"98","author":"Li","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yrtph.2016.02.016","article-title":"A 90-day subchronic toxicity study with sodium formononetin-3'-sulphonate (Sul-F) delivered to dogs via intravenous administration","volume":"77","author":"Li","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib12","article-title":"Repeated-dose 26-week oral toxicity study of ginsenoside compound K in Beagle dogs","volume":"248","author":"Li","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.yrtph.2015.09.010","article-title":"Acute toxicity of sodium for mononetin-3'- sulphonate (Sul-F) in Sprague-Dawley rats and Beagle dogs","volume":"72","author":"Li","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104781_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108817","article-title":"Xuezhikang improves the outcomes of cardiopulmonary resuscitation in rats by suppressing the inflammation response through TLR4\/NF-\u03baB pathway","volume":"114","author":"Liang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yrtph.2020.104781_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2016.04.013","article-title":"Safety assessment of non-animal chondroitin sulfate sodium: subchronic study in rats, genotoxicity tests and human bioavailability","volume":"93","author":"Miraglia","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2020.104781_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jcpt.12374","article-title":"Systematic review of red yeast rice compared with simvastatin in dyslipidaemia","volume":"41","author":"Ong","year":"2016","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.yrtph.2020.104781_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188841","article-title":"Xuezhikang, an extract from red yeast rice, attenuates vulnerable plaque progression by suppressing endoplasmic reticulum stress-mediated apoptosis and inflammation","volume":"12","author":"Shen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.yrtph.2020.104781_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1536\/ihj.16-163","article-title":"Effects of statins and xuezhikang on the expression of secretory phospholipase A2, group IIA in rat vascular smooth muscle cells","volume":"58","author":"Xie","year":"2017","journal-title":"Int. Heart J."},{"key":"10.1016\/j.yrtph.2020.104781_bib19","first-page":"117","article-title":"Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans","volume":"4","author":"Xu","year":"2017","journal-title":"Chronic Dis. Transl. Med."},{"key":"10.1016\/j.yrtph.2020.104781_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1532-5415.2007.01230.x","article-title":"Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study","volume":"55","author":"Ye","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.yrtph.2020.104781_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exger.2014.12.017","article-title":"Effect of Eclipta prostrata on lipid metabolism in hyperlipidemic animals","volume":"62","author":"Zhao","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.yrtph.2020.104781_bib22","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20176363","article-title":"Xuezhikang reduced arterial stiffness in patients with essential hypertension: a preliminary study","volume":"50","author":"Zheng","year":"2017","journal-title":"Braz. J. Med. Biol. Res."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230020302075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230020302075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:31:27Z","timestamp":1759494687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230020302075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"alternative-id":["S0273230020302075"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2020.104781","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 26-week toxicological study of Xuezhikang (XZK), red yeast rice extract, in Beagle dogs with a 4-week recovery period","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2020.104781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104781"}}